These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 36565118)

  • 1. Cerebrospinal Fluid Biomarkers and Amyloid-β Elimination from the Brain in Cerebral Amyloid Angiopathy-Related Inflammation.
    Sakai K; Noguchi-Shinohara M; Tanaka H; Ikeda T; Hamaguchi T; Kakita A; Yamada M; Ono K
    J Alzheimers Dis; 2023; 91(3):1173-1183. PubMed ID: 36565118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.
    Renard D; Wacongne A; Ayrignac X; Charif M; Fourcade G; Azakri S; Le Floch A; Bouly S; Marelli C; Arquizan C; Hirtz C; Gabelle A; Thouvenot E; Lehmann S
    J Alzheimers Dis; 2016; 50(3):759-764. PubMed ID: 26757185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal Fluid Profile of Tau, Phosphorylated Tau, Aβ42, and Aβ40 in Probable Cerebral Amyloid Angiopathy.
    Grangeon L; Paquet C; Guey S; Zarea A; Martinaud O; Rotharmel M; Maltête D; Quillard-Muraine M; Nicolas G; Charbonnier C; Chabriat H; Wallon D
    J Alzheimers Dis; 2022; 87(2):791-802. PubMed ID: 35367960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral Amyloid Angiopathy and Cerebral Amyloid Angiopathy-Related Inflammation: Comparison of Hemorrhagic and DWI MRI Features.
    Renard D; Tatu L; Collombier L; Wacongne A; Ayrignac X; Charif M; Boukriche Y; Chiper L; Fourcade G; Azakri S; Gaillard N; Mercier E; Lehmann S; Thouvenot E
    J Alzheimers Dis; 2018; 64(4):1113-1121. PubMed ID: 30010128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling amyloid-β peptides as biomarkers for cerebral amyloid angiopathy.
    van den Berg E; Kersten I; Brinkmalm G; Johansson K; de Kort AM; Klijn CJM; Schreuder FHBM; Gobom J; Stoops E; Portelius E; Gkanatsiou E; Zetterberg H; Blennow K; Kuiperij HB; Verbeek MM
    J Neurochem; 2024 Jul; 168(7):1254-1264. PubMed ID: 38362804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy.
    Banerjee G; Ambler G; Keshavan A; Paterson RW; Foiani MS; Toombs J; Heslegrave A; Dickson JC; Fraioli F; Groves AM; Lunn MP; Fox NC; Zetterberg H; Schott JM; Werring DJ
    J Alzheimers Dis; 2020; 74(4):1189-1201. PubMed ID: 32176643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy: A meta-analysis.
    Charidimou A; Friedrich JO; Greenberg SM; Viswanathan A
    Neurology; 2018 Feb; 90(9):e754-e762. PubMed ID: 29386280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma amyloid beta 42 is a biomarker for patients with hereditary, but not sporadic, cerebral amyloid angiopathy.
    de Kort AM; Kuiperij HB; Jäkel L; Kersten I; Rasing I; van Etten ES; van Rooden S; van Osch MJP; Wermer MJH; Terwindt GM; Schreuder FHBM; Klijn CJM; Verbeek MM
    Alzheimers Res Ther; 2023 Jun; 15(1):102. PubMed ID: 37270536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies.
    Piazza F; Greenberg SM; Savoiardo M; Gardinetti M; Chiapparini L; Raicher I; Nitrini R; Sakaguchi H; Brioschi M; Billo G; Colombo A; Lanzani F; Piscosquito G; Carriero MR; Giaccone G; Tagliavini F; Ferrarese C; DiFrancesco JC
    Ann Neurol; 2013 Apr; 73(4):449-58. PubMed ID: 23625526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased Cerebrospinal Fluid Amyloid β 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy.
    De Kort AM; Kuiperij HB; Marques TM; Jäkel L; van den Berg E; Kersten I; van Berckel-Smit HEP; Duering M; Stoops E; Abdo WF; Rasing I; Voigt S; Koemans EA; Kaushik K; Warren AD; Greenberg SM; Brinkmalm G; Terwindt GM; Wermer MJH; Schreuder FHBM; Klijn CJM; Verbeek MM
    Ann Neurol; 2023 Jun; 93(6):1173-1186. PubMed ID: 36707720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Levels of Cerebrospinal Fluid/Plasma Aβ40 as an Early Biomarker for Cerebral Amyloid Angiopathy in RTg-DI Rats.
    Zhu X; Xu F; Hoos MD; Lee H; Benveniste H; Nostrand WEV
    Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31906317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core CSF Biomarker Profile in Cerebral Amyloid Angiopathy: Updated Meta-Analysis.
    Charidimou A; Boulouis G
    Neurology; 2024 Oct; 103(7):e209795. PubMed ID: 39270153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid cytokines and metalloproteinases in cerebral amyloid angiopathy-related inflammation.
    Sakai K; Noguchi-Shinohara M; Ikeda T; Hamaguchi T; Ono K; Yamada M
    Acta Neurol Scand; 2021 Apr; 143(4):450-457. PubMed ID: 33247941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Origins of Beta Amyloid Differ Between Vascular Amyloid Deposition and Parenchymal Amyloid Plaques in the Spinal Cord of a Mouse Model of Alzheimer's Disease.
    Yuan Q; Liu X; Xian YF; Tang Y; Zou J; Zhang X; Huang P; Wu W; Song YQ; Lin ZX
    Mol Neurobiol; 2020 Jan; 57(1):278-289. PubMed ID: 31325023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Aβ reduction prevents progression of cerebral amyloid angiopathy.
    Schelle J; Wegenast-Braun BM; Fritschi SK; Kaeser SA; Jährling N; Eicke D; Skodras A; Beschorner N; Obermueller U; Häsler LM; Wolfer DP; Mueggler T; Shimshek DR; Neumann U; Dodt HU; Staufenbiel M; Jucker M
    Ann Neurol; 2019 Oct; 86(4):561-571. PubMed ID: 31359452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria.
    Renard D; Castelnovo G; Wacongne A; Le Floch A; Thouvenot E; Mas J; Gabelle A; Labauge P; Lehmann S
    J Neurol; 2012 Nov; 259(11):2429-33. PubMed ID: 22576334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different Aβ43 deposition patterns in the brains of aged dogs, sea lions, and cats.
    Takahashi K; Chambers JK; Takaichi Y; Uchida K
    J Vet Med Sci; 2022 Nov; 84(12):1563-1573. PubMed ID: 36288928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral Amyloid Angiopathy-Related Microbleeds and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease.
    Noguchi-Shinohara M; Komatsu J; Samuraki M; Matsunari I; Ikeda T; Sakai K; Hamaguchi T; Ono K; Nakamura H; Yamada M
    J Alzheimers Dis; 2017; 55(3):905-913. PubMed ID: 27802236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid biomarkers and apolipoprotein E genotype in cerebral amyloid angiopathy. A narrative review.
    Theodorou A; Tsantzali I; Kapaki E; Constantinides VC; Voumvourakis K; Tsivgoulis G; Paraskevas GP
    Cereb Circ Cogn Behav; 2021; 2():100010. PubMed ID: 36324707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease.
    Shinohara M; Murray ME; Frank RD; Shinohara M; DeTure M; Yamazaki Y; Tachibana M; Atagi Y; Davis MD; Liu CC; Zhao N; Painter MM; Petersen RC; Fryer JD; Crook JE; Dickson DW; Bu G; Kanekiyo T
    Acta Neuropathol; 2016 Aug; 132(2):225-234. PubMed ID: 27179972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.